v3.26.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 14, 2026
Jan. 08, 2026
Dec. 09, 2022
Apr. 20, 2026
Dec. 17, 2025
Dec. 17, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2026
Jun. 30, 2025
Dec. 15, 2025
Mar. 17, 2025
Proceeds from warrants exercised                   $ 1,362,932      
Sales agreement [Member]                          
Common stock shares sold             1,794,185 318,411   2,623,926 368,411    
Amount increased for sale of common stock       $ 51,404,500                  
Proceeds from sale of common stock             $ 21,339,571 $ 390,813   $ 27,883,978 $ 507,248    
Payment for commission to investment banking             491,451 $ 12,088   695,053 $ 15,689    
Payment for underwriting expenses             $ 18,139     $ 56,861      
Institutional investor [Member] | Purchase agreement [Member]                          
Agreement to sell invest common stock value upper limit institutional investor                         30,000,000
Purchase agreement amount received                       $ 3,646,655  
Institutional investor [Member] | 2023 Purchase Agreement [Member]                          
Agreement to sell invest common stock value upper limit institutional investor                         30,000,000
Investment Bank [Member]                          
Underwriter warrants exercised 402,500                        
Proceeds from warrants exercised $ 1,362,932                        
Investment Bank [Member] | Sales agreement [Member]                          
Agreement to sell invest common stock value upper limit investment bank         11,666,667 11,666,667              
Additional shares issued   1,750,000     1,750,000                
Underwriter warrants purchase           350,000              
Common stock sold in offering rate         3.00%                
Additional underwriter warrants purchased         52,500                
Common stock shares sold   1,750,000     11,666,667                
Proceeds from shares issued   $ 4,930,928     $ 32,825,700                
Exercise price         $ 3.45 $ 3.45              
Debt instrument, term         5 years                
Investment banking company [Member] | Sales agreement [Member]                          
Increase in the amount of shares of common stock that may be sold     $ 35,000,000 $ 51,404,500         $ 35,000,000        
Commission rate     3.00%